![Novo Nordisk battling $3.9 billion TP adjustment on transfer of biopharmaceutical division | International Tax Review Novo Nordisk battling $3.9 billion TP adjustment on transfer of biopharmaceutical division | International Tax Review](https://assets.euromoneydigital.com/dims4/default/d228201/2147483647/strip/true/crop/200x200+0+0/resize/800x800!/quality/90/?url=http%3A%2F%2Feuromoney-brightspot.s3.amazonaws.com%2F36%2F68%2Fd3439a6da9fbca785b4d015c1f43%2Fnovo-nordisk.jpg)
Novo Nordisk battling $3.9 billion TP adjustment on transfer of biopharmaceutical division | International Tax Review
![Norditropin NordiFlex®: Introducing the Next Innovation in Growth Hormone Therapy | Latest news for Doctors, Nurses and Pharmacists | Paediatrics Norditropin NordiFlex®: Introducing the Next Innovation in Growth Hormone Therapy | Latest news for Doctors, Nurses and Pharmacists | Paediatrics](https://pubmiddleware.mims.com/resource/image/D65E0DD8-8B2D-4CDA-ABE3-AC750142EA21/OriginalThumbnail/THUMBNAIL_NordiFlex_5-10mg_NEW.jpg)
Norditropin NordiFlex®: Introducing the Next Innovation in Growth Hormone Therapy | Latest news for Doctors, Nurses and Pharmacists | Paediatrics
![These highlights do not include all the information needed to use NORDITROPIN safely and effectively. See full prescribing information for NORDITROPIN. NORDITROPIN ® (somatropin) injection, for subcutaneous useInitial U.S. Approval: 1987 These highlights do not include all the information needed to use NORDITROPIN safely and effectively. See full prescribing information for NORDITROPIN. NORDITROPIN ® (somatropin) injection, for subcutaneous useInitial U.S. Approval: 1987](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-101.jpg&id=669792)